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Probing Structural Determinants Distal
to the Site of Hydrolysis that Control
Substrate Specificity of the 20S Proteasome
amide bond by the hydroxyl nucleophile on the catalytic
threonine (Figure 1A).
Since its discovery as a multicatalytic protease activ-
ity, the primary hydrolytic activities of the proteasome
have been defined based on the identity of the amino
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2 Department of Biochemistry and Biophysics acid found directly adjacent to the site of peptide bond
hydrolysis [5–7]. These primary activities were initiallyUniversity of California, San Francisco
San Francisco, California 94143 defined by hydrolysis of fluorogenic peptide substrates
and are termed the chymotrypsin-like (cleavage after
hydrophobic residues), trypsin-like (cleavage after basic
residues), and post glutamyl peptide hydrolyzing (PGPH)Summary
or caspase-like (cleavage after acidic residues) activities
[8]. Studies of mutant enzymes in yeast as well as studiesThe 20S proteasome is a large multicomponent prote-
utilizing specific inhibitors in mammalian cells havease complex. Relatively little is known about the mech-
helped to establish the roles of individual catalytic sub-anisms that control substrate specificity of its multiple
units in generating each of the primary hydrolysis activi-active sites. We present here the crystal structure at
ties [9–14]. These studies have linked the 1 subunit to2.95 A˚ resolution of a 2-selective inhibitor (MB1)
the PGPH activity, the 2 subunit to the trypsin-likebound to the yeast 20S proteasome core particle (CP).
activity, and the 5 subunit to the chymotrypsin-likeThis structure is compared to the structure of the CP
activity.bound to a general inhibitor (MB2) that covalently mod-
Recently, several studies using peptide-based inhibi-ified all three (1, 2, 5) catalytic subunits. These
tors and peptide substrates have demonstrated an im-two inhibitors differ only in their P3 and P4 residues,
portant role for amino acid residues distal to the site ofthereby highlighting binding interactions distal to the
hydrolysis [12, 13, 15–19]. In particular, the P3 and P4active site threonine that control absolute substrate
positions play an important role in determining substratespecificity of the complex. Comparisons of the CP-
binding to each of the active sites in the complex. Thesebound structures of MB1, MB2, and the natural prod-
results indicate the importance of non-P1 interactionsucts epoxomycin and TMC-95A also provide informa-
responsible for defining the absolute substrate specific-tion regarding general binding modes for several
ity of the multiple active sites of the proteasome.classes of proteasome inhibitors.
We present here the crystal structures of two peptide
vinyl sulfones covalently bound to the yeast 20S protea-
Introduction some complex. We have selected two compounds that
differ in structure only in their P3 and P4 amino acid
The eukaryotic proteasome is a multicomponent proteo- residues but that differ dramatically with respect to their
lytic machine that contains multiple active sites within a subunit selectivity. The first inhibitor, MB1, binds only
central 20S core particle (CP). Further complexity results to the 2 active site while the other, MB2, binds to all
from the exchange of catalytic components upon three catalytic subunits (1, 2, 5). The structures of
-interferon stimulation, as well as the multitude of ac- these inhibitors provide insight into the global patterns
cessory proteins that can modulate the activity of the of subunit specificity identified previously through li-
CP [1]. Regardless of these complexities of function, the brary screening. Furthermore, overlay of the structure
structure and catalytic mechanism of the core particle of of MB1 bound into the active site of 2 with that of
the proteasome have been firmly established [2–4]. the nonsubunit selective, reversible inhibitor TMC-95A
The 20S proteasome is a large barrel-shaped protein indicates a possible mechanism by which subunit-selec-
complex composed of four rings of tightly packed sub- tive noncovalent inhibitors can be designed.
units stacked upon one another. These rings of the 20S
core particle are made up of proteins that can be classi-
fied into  and  subfamilies. The  subunits, constitut- Results and Discussion
ing the top and bottom of the four ring stack, have
substrate gating functions, while the  subunits supply A number of elegant techniques have been developed
the catalytic machinery found within the two central to define global rules of primary substrate specificity of
rings of the complex. In eukaryotes there are seven proteases [20–23]. These methods make use of libraries
unique  and seven unique  subunits, each present in of peptide substrates that allow optimal sequences to be
duplicate within a single CP. Of these seven  subunits selected for a given purified enzyme. These sequences
(1–7), only three (1, 2, 5) possess a catalytic N- then provide information regarding the primary se-
terminal threonine residue required for hydrolysis of a quence specificity of the enzyme. However, such meth-
protein substrate. Hydrolysis is initiated by attack of an ods cannot be used for analysis of multicatalytic en-
zymes such as the proteasome due to the inability of the
assay to resolve hydrolysis at multiple locations within a3 Correspondence: mbogyo@biochem.ucsf.edu (M.B.), groll@
biochem.mpg.de (M.G.) single enzyme complex. To circumvent these problems,
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Figure 1. Catalytic Mechanism of the 20S Proteasome
(A) Peptide bond hydrolysis by the N-terminal threonine residue of a catalytic  subunit within the proteasome 20S core particle.
(B) Mechanism of covalent inhibition of the proteasome by Michael attack of a vinyl sulfone by the catalytic hydroxyl nucleophile of a proteasomal
 subunit.
our laboratory previously developed libraries of peptide- substrate (Boc-LRR-MCA) while MB2 inhibited hydroly-
sis of the chymotrypsin-like (Suc-LLVY-MCA), trypsin-based covalent inhibitors of the proteasome [12]. These
inhibitors bind in a manner analogous to a bona fide like, and PGPH (Ac-LLE-MCA) substrates (data not
shown).protein substrate but are covalently locked into place
by a nucleophilic attack on the inhibitory “warhead”
(Figure 2B). Using this approach, it is possible to indi- Structure of MB1 Bound to the 2 Subunit: Critical
Binding Determinants at the P3/S3 Interfacerectly determine the optimal sequences of inhibitors
bound at each of the three primary active sites. Further- To obtain the structures of the inhibitor-bound 20S pro-
teasomes, crystals were soaked for 6 hr with the inhibi-more, the assay can be performed in crude protein ex-
tracts under a variety of conditions. tors. Determination of the three-dimensional structures
of the complexes indicated that, as expected, MB1 wasWe chose two tetra-peptide vinyl sulfone inhibitors
based on data obtained from this library approach [12] covalently bound to only the 2 active site while MB2
was bound to the active sites of 1, 2, and 5. The(Table 1). Results from this screening process indicated
that selection of a positively charged basic residue at structure of the 2 active site containing the covalently
bound MB1 ligand (Ac-PRLN-VS) shows the P3 argininethe P3 position results in selectivity for the 2 subunit
responsible for the trypsin-like activity of the protea- residue projected into a deep acidic pocket at the S3
subsite (Figure 2A). The P1 asparagine is likewise buriedsome. The library data also indicated that a proline or
tyrosine residue at P4 further increases specificity for into a slightly less pronounced acidic S1 pocket. The
large size and the acidic nature of the S3 pockets ex-the 2 subunit. We therefore chose the peptide Ac-
PRLN-VS (MB1) as our 2-selective inhibitor. This com- plains the reason for favorable selection of lysine and
arginine residues at the P3 position of the previouslypound was previously shown to bind exclusively to the
2 subunit at concentrations as high as 100 M, sug- identified 2-specific inhibitors [12]. In addition to the
overall acidic nature of the S3 pocket, several residuesgesting that it is unable to occupy the active sites of 1
and 5. The library results also indicated that simple within this site are available for hydrogen bonding inter-
actions with the side chain nitrogen residues of argininereplacement of the basic residue at P3 with an aliphatic
leucine residue abolishes the selectivity of the inhibitor. (Figure 2B). In particular, aspartic acid 28 of the 2 sub-
unit and cysteine 118 of the adjacent 3 subunit projectWe therefore chose the sequence Ac-YLLN-VS as a gen-
eral inhibitor that differed from MB1 only in the P3 and into the S3 pocket and make favorable hydrogen bond
interactions with nitrogens of the P3 arginine. TheseP4 residues. This compound was shown to bind equally
well to each of the three active sites. Assay of these interactions are likely to be one of the critical determi-
nants for selectivity at the S3 site of the trypsin-likeinhibitors against purified 20S proteasomes indicated
that MB1 inhibited hydrolysis of only the trypsin-like active site.
Substrate Specificity of the Proteasome
657
Figure 2. Structure of the 2-Specific Inhibitor MB1 Bound to the Trypsin-Like Active Site of the Yeast 20S Proteasome
(A) Surface model of MB1 bound in the trypsin-like active site with contacts to the 2 and 3 subunits. The catalytic N-terminal threonine is
covalently linked to the inhibitor and is shown in black. Colors indicate positive and negative electrostatic potential contoured from 15kT/e (intense
blue) to 15 kT/e (intense red).
(B) Wire frame structure of MB1 bound in the trypsin-like active site. Favorable hydrogen bonds between Asp28 of 2 at the bottom of the S3
pocket and Cys118 of 3 within the walls of the S3 pocket are shown. These residues make productive contacts with the amine groups of the P3
arginine of MB1.
The P2 and P4 residues of MB1 appear to play only bonds may help explain why the vinyl sulfones react
covalently with the hydroxyl nucleophile of the protea-a minor role in contributing to the binding interactions
between the inhibitor and the 2 active site. The P2 some even though these electrophiles were originally
designed as mechanism-based inhibitors of cysteineresidue, in particular, projects into the central core of
the 20S cavity, making little or no contacts with the 2 proteases [24]. Such hydrogen bonding interactions
may be important for activation of the electrophilic vinylsubunit. The P4 proline residues forces a slight kink in
the inhibitor backbone that causes the N-terminal por- carbons as well as to retain the bound inhibitor in the
active site, thereby increasing the likelihood of a cova-tion of the inhibitor to bend away from the inner cavity
wall and reduces the contacts between the inhibitor and lent attack by the hydroxyl nucleophile.
the adjacent 3 subunit. Furthermore, the S4 pocket of
2 is quite small, thereby making the proline in P4 an Structure of MB2 Bound to the 1, 2, and 5
Subunits: Potential Conflicts at S3?ideal residue for binding to this subunit. This relatively
small S4 pocket may also represent a means for creating In addition to the favorable interactions of MB1 with the
2 active site, we wished to explore whether additionalinhibitors that can be excluded from binding to 2
through addition of bulky hydrophobic groups at the P4 nonfavorable interactions exist that would exclude MB1
from binding to the 1 and 5 active sites. To exploreposition.
The vinyl sufone group forms a covalent bond with the reasons for lack of binding at 1 and 5, we deter-
mined the structure of the core particle bound to thethe hydroxyl residue of the N-terminal threonine. Strong
binding interactions result from three hydrogen bonds compound MB2. Figure 3 shows the surface structures
of the inhibitor bound into each of the three primarybetween the sulfone oxygens and backbone amides as
well as the free amino terminus of Thr1. These hydrogen active sites of the complex.
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Table 1. Chemical Structures and Subunit Specificities of the Two Peptide Vinyl Sulfone Proteasome Inhibitors
MB2 adopted a similar binding mode within all three cated that while the 1/2 and 5/6 S3 sites lacked
the residues for hydrogen bond interactions with theactive sites. Furthermore, its orientation was similar to
P3 arginine of MB1, neither structure indicated sites ofthat of MB1, binding such that the P1 and P3 residues
steric or electrostatic clashes. These findings suggestmade direct contacts with the cavity walls while the P2
that simply losing favorable interactions at the S3-P3and P4 residues projected in the opposite direction.
interface are sufficient to prevent covalent modificationHowever, several minor differences between the back-
at the catalytic nucleophile two residues away. Whilebone structures of MB1 and MB2 were observed. The
covalent inhibitors may not perfectly mimic a true pro-most noticeable difference was observed for the P4
tein substrate, these results suggest that interactionstyrosine residue of MB2. This large phenolic ring was
at the S3 site may drive selectivity by effectively holdingoriented so that it made favorable binding contacts with
a substrate in place long enough for hydrolysis to occur.the adjacent subunits that make up the extended S4
Analysis of the S1 pockets of each of the three activepockets of each of the three active sites. In particular,
sites occupied by the asparagine of MB2 indicate thatthe contacts between the P4 tyrosine and the S4 pocket
these relatively shallow pockets are able to accommo-of the 5/6 chymotrypsin site seemed to be critical
date an amide side chain regardless of the topology andfor favorable binding. This result is consistent with the
electrostatic character observed for each active site. Infinding that tetrapeptides that contain a hydrophobic
the case of the 2 subunit, the S1 site contains an acidicP4 residue are potent inhibitors of the chymotrypsin-
pocket that would be expected to interact favorably withlike activity but can be rendered completely inactive
the P1 side chain amide of MB2. Likewise, the shallowupon removal of the P4 residue [15]. Furthermore, addi-
S1 pocket of 5 contains a methionine residue thattion of P4 residue to known tripeptide cysteine protease
would be expected to tolerate the P1 asparagine resi-
inhibitors can likewise result in increased cross-reactiv-
due. However, the basic character of the S1 binding site
ity with the proteasome (unpublished data). These re- of 1 would be predicted to disfavor binding of the P1
sults are also consistent with the P3 and P4 positions residue of MB2. The fact that MB2 is able to be cova-
on a substrate making the primary interactions with the lently bound to each of these active sites with relatively
5/6 interface that control the sequence specificity at diverse S1 pockets suggests that this site may in fact
this site. be of secondary importance to interactions that take
In the case of all three primary active sites, the S3 place at the S3 and S4 subsites. This model for binding is
pockets are large open spaces created at the interfaces further supported by the finding that the overall electron
between the primary catalytic subunits and the back- density for MB2 bound in each of the three active sites
sides of adjacent  subunits. Since these pockets are is low, indicating relatively poor binding interactions
large, it seemed unlikely that they would be capable overall. However, the fact that MB2 serves as a reason-
of excluding specific side chain residues, even large ably potent inhibitor and forms covalent interactions
positively charged groups such as arginine. To confirm with each active site suggests that even with unfavor-
this, we superimposed the structure of the 2 bound able P1 interactions, it may be possible for a peptide
MB1 onto that of MB2 bound to both 1 and 5 to substrate to be hydrolyzed. In the case of MB1, strong
determine if potential steric or electrostatic clashes ex- favorable interactions at P3 in the 2/3 trypsin site
isted that could further explain the high degree of selec- make up for the relatively poor P1 residue, leading to a
highly selective inhibitor.tivity of MB1 (data not shown). These structures indi-
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Figure 3. Structures of MB2 Bound into Each of the Three Primary Active Sites of the Proteasome
MB2 covalently bound into the PGPH active site (top panels), the trypsin-like site (middle panels), and the chymotrypsin-like site (bottom panels).
The S3 site is found at the interface between each catalytic  subunit and its nearest neighbor subunit. Note the overall similarity in the binding
mode of the inhibitor regardless of the net charge in the P1 pocket. In all cases, the S3 subsite is the largest pocket and is occupied by the critical
P3 residue of the inhibitor. Colors indicate positive and negative electrostatic potential contoured from 15kT/e (intense blue) to 15 kT/e (intense
red).
Overlay of MB1, MB2, Epoxomicin, and TMC-95A reported [25, 26]. These structures can be used to com-
pare the overall binding topology of multiple inhibitorsBackbone Structures: Implications for the Design
of Subunit-Selective Noncovalent Inhibitors within the active sites of the proteasome. Overlay of the
structures of MB1, MB2, and epoxomicin bound to theThe crystal structures of the natural products epoxo-
micin and TMC-95A (for chemical structures see Figure 20S proteasome indicate a remarkable similarity in over-
all geometry (Figure 4B). In particular, the backbone4A) bound to the 20S proteasome have recently been
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Figure 4. Comparison of Proteasome Bound MB1 and MB2 Structures with the Structures of the Natural Products Epoxomicin and TMC-95A
(A) Chemical structures of the natural products epoxomicin and TMC-95A.
(B) Superimposition of the coordinates of MB1 (light green), MB2 (dark green), and epoxomicin (yellow) bound to subunit 2. All three inhibitors
have a similar peptide backbone but different side chain residues and electrophilic “warheads.” Note the general binding mode for all three inhibitors
within an active site of the proteasome.
(C) Overlay of bound structure of MB1 with TMC-95A. The overlay reveals the amide moiety of TMC-95A that mimics the P3 residue of the specificity
determining arginine of MB1.
structures of all three bound inhibitors are nearly identi- and MB2 and suggests that inter-side chain interactions
play little if any role in how the inhibitor is presented tocal, suggesting that each compound is rigidly held in
position such that its side chains are projected toward the active site. It also indicates that changes in overall
backbone structure resulting from a change from P3the binding pockets of the protein in a specific manner.
This finding is particularly surprising considering the leucine (MB2) to P3 arginine (MB1) are not responsible
for the high degree of subunit selectivity of MB1.relatively dissimilar primary sequence and type of elec-
trophiles found on epoxomicin when compared to MB1 The rigidity with which straight chain peptide-based
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Table 2. Crystal Data
YLLN-VS PRLN-VS
Cell constants (A˚) a  136.5; b  302.0; c  145.0;   112.6 a  135.8; b  301.1; c  144.0;   112.8
Resolution (A˚) 50–2.95 50–3.1
Observation, 2 1,150,929 436,438
Uniques 299,192 141,363
Completeness 98.0 90.5
Rmerge % 8.4 13.9
R/Rfree % 25.8/29.8 26.6/32.9
Rms bonds, A˚ 0.013 0.013
Rms angles,  1.885 2.009
inhibitors bind to each of the multiple active sites teractions. Taken together, these results suggest a
model in which specificity can be controlled predomi-prompted us to compare the bound structures of MB1
with that of the cyclic peptide natural product TMC-95A. nantly by interactions at the S3 site for substrates with
favorable interactions at this site and poor interactionsThis noncovalent small molecule shows strong binding
to primarily the chymotrypsin-like site of the 20S protea- at other sites. However, strong interactions at P1 may
overcome the need for a favorable P3 residue. Thissome. Analysis of the TMC-95A structure overlaid with
that of MB1 shows remarkable overlap with both the model for substrate binding may aid in the development
of inhibitors of the proteasome with tunable selectivitybackbone amides and the P1 asparagine and P3 argi-
nine residues (Figure 4C). Since TMC-95 interacts with for each of the active sites. The proteasome-bound
structures of MB1, MB2, and the natural productsthe proteasome in a reversible manner, it must be capa-
ble of presenting functional groups in such a way that epoxomicin and TMC-95A indicate a highly conserved
binding mode that could facilitate design of rigid scaf-covalent attachment to the catalytic nucleophile is no
longer required. The exceptional potency of the TMC- folds that display functional groups to the critical sub-
strate binding pockets within each active site. Such95 analogs indicates that tight binding interactions at
these two sites must be sufficient to lock the inhibitors compounds may be effective for disrupting protein
breakdown in a controlled manner, thereby reducingin the active site and inhibit turnover of substrates.
Coupling information from the structures of MB1, the overall toxicity associated with complete inhibition
of all three active sites.MB2, and TMC-95A suggests that it should be possible
to generate a scaffold based on the geometry of the
bound TMC-95A that can present a variety of structures Experimental Procedures
to the S1 and S3 pockets in each of the active sites of
the proteasome. By modulating these structures with Selection and Synthesis of Covalent Inhibitors
Tetrapeptide vinyl sulfones MB1 and MB2 were selected based onrespect to the P3 position, it should be possible to fine-
positional scanning library data generated for the proteasome intune the selectivity of the compounds for individual 
crude cell homogenates [12]. Compounds were synthesized usingsubunits. The results from the MB1 structure presented
a mixture of solution and solid phase chemistries as previously
here support the fact that simple hydrogen bonding in- described [12]. Compounds were first tested for potency against
teractions at the S3-P3 interface can be sufficient to the three primary activities of purified 20S proteasomes. The results
of these preliminary screens are reported elsewhere [12].control this absolute specificity.
Significance Structure Determination
Crystals of 20S proteasome from S. cerevisiae were grown in hang-
ing drops at 24C as described previously [4] and incubated for 6The proteasome is a large, multicatalytic protease
hr with the vinyl sulfone compounds. The protein concentration usedcomplex responsible for breakdown of most cytosolic
for crystallization was 40 mg/ml in 10 mM Tris-HCl (pH 7.5) and 1proteins [1]. While its three-dimensional structure and
mM EDTA. The drops contained 3 l protein and 2 l of the reservoirmechanism of hydrolysis have been determined, little
solution containing 30 mM magnesium acetate, 100 mM morpho-
is known about the elements that control the primary lino-ethane-sulphonic acid (pH 7.2), and 10% MPD.
sequence specificity of the complex. Previous work The space group of the crystals belongs to P21 (see Table 2). Data
were collected using synchrotron radiation with 	1.05 A˚ on theusing libraries of peptide-based covalent inhibitors
ID14-beamline at ESRF/Grenoble/France. Crystals were soaked inhas identified structural elements that can be used to
a cryoprotecting buffer (30% MPD, 20 mM magnesium acetate, 100control the substrate selectivity of synthetic inhibitors
mM morpholino-ethane-sulfonic acid [pH 6.9]) for 30 s and frozen[12, 13]. We present here the structures of two covalent
in a stream of liquid nitrogen gas at 90 K (Oxford Cryo Systems).
inhibitors, MB1 and MB2, that differ only in their P3 X-ray intensities were evaluated by using the MOSFILM program
and P4 residues, bound to the core 20S proteasome package (version 6.1) and data reduction was performed with CCP4
[27]. The anisotropy of diffraction was corrected by an overall aniso-particle. These structures suggest that favorable inter-
tropic temperature factor by comparing observed and calculatedactions between the P3 residue of MB1 and the large
structure amplitudes using the program X-PLOR [28]. Electron den-S3 pocket generated at the interface of the 2 and 3
sity was averaged 10 times over the 2-fold noncrystallographic sym-subunits are responsible for driving inhibitor selectiv-
metry axis using the program package MAIN [29]. Conventional
ity. Furthermore, the P1 asparagine of MB1 and MB2 crystallographic rigid body, positional, and temperature factor re-
was bound in the S1 pocket of each of the active sites, finements were carried out with X-PLOR using the yeast 20S protea-
some structure [4] as a starting model. For model building, theregardless of seemingly unfavorable electrostatic in-
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program FRODO was used [30]. Modeling experiments were per- thesis and evaluation of peptide alpha
,beta
-epoxyketones.
Chem. Biol. 6, 811–822.formed using the coordinates of yeast 20S proteasome with MAIN.
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